Pub. Date : 2005 Oct
PMID : 16230218
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness. | Cefepime | EsbL | Escherichia coli |
2 | OBJECTIVE: To determine the affect of ESBL production among Klebsiella species and Escherichia coli on cefepime effectiveness. | Cefepime | EsbL | Escherichia coli |
3 | METHODS: This was a retrospective, case-controlled study comparing the clinical and microbiologic responses of patients receiving cefepime for ESBL producing Klebsiella species or E. coli from a non-urine source with matched controls receiving cefepime for non-ESBL strains. | Cefepime | EsbL | Escherichia coli |
4 | METHODS: This was a retrospective, case-controlled study comparing the clinical and microbiologic responses of patients receiving cefepime for ESBL producing Klebsiella species or E. coli from a non-urine source with matched controls receiving cefepime for non-ESBL strains. | Cefepime | EsbL | Escherichia coli |
5 | CONCLUSION: These data indicate that ESBL production among non-urinary Klebsiella species and E. coli negatively affected cefepime effectiveness. | Cefepime | EsbL | Escherichia coli |